ATE290012T1 - Methode für die herstellung von gereinigtem invasinprotein und seine anwendung - Google Patents

Methode für die herstellung von gereinigtem invasinprotein und seine anwendung

Info

Publication number
ATE290012T1
ATE290012T1 AT99970664T AT99970664T ATE290012T1 AT E290012 T1 ATE290012 T1 AT E290012T1 AT 99970664 T AT99970664 T AT 99970664T AT 99970664 T AT99970664 T AT 99970664T AT E290012 T1 ATE290012 T1 AT E290012T1
Authority
AT
Austria
Prior art keywords
application
producing purified
invasin protein
purified invasin
highly purified
Prior art date
Application number
AT99970664T
Other languages
English (en)
Inventor
William D Picking
Wendy L Picking
Edwin V Oaks
Original Assignee
Univ Kansas Ct For Res Inc
Us Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas Ct For Res Inc, Us Army filed Critical Univ Kansas Ct For Res Inc
Application granted granted Critical
Publication of ATE290012T1 publication Critical patent/ATE290012T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99970664T 1998-10-21 1999-10-21 Methode für die herstellung von gereinigtem invasinprotein und seine anwendung ATE290012T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10508598P 1998-10-21 1998-10-21
US13675499P 1999-06-01 1999-06-01
PCT/US1999/024931 WO2000023462A1 (en) 1998-10-21 1999-10-21 Method for the production of purified invasin protein and use thereof

Publications (1)

Publication Number Publication Date
ATE290012T1 true ATE290012T1 (de) 2005-03-15

Family

ID=26802247

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99970664T ATE290012T1 (de) 1998-10-21 1999-10-21 Methode für die herstellung von gereinigtem invasinprotein und seine anwendung

Country Status (7)

Country Link
US (1) US20070202124A1 (de)
EP (1) EP1131338B1 (de)
AT (1) ATE290012T1 (de)
AU (1) AU1227700A (de)
CA (1) CA2347937A1 (de)
DE (1) DE69923996D1 (de)
WO (1) WO2000023462A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025058D0 (en) * 2000-10-12 2000-11-29 Smithkline Beecham Biolog Composition
EP1701737B1 (de) * 2003-11-25 2010-01-13 THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY Verwendung von shigella invaplex für den transport von funktionalen proteinen und transkriptionsaktiven nukleinsäuren durch säugetier-zellmembranen in vitro und in vivo
US7833740B2 (en) 2005-08-07 2010-11-16 Tgc Biomics Gmbh Test system for detecting salmonella
DE102005037796A1 (de) * 2005-08-07 2007-02-08 Tgc Biomics Gmbh Testsystem zum Nachweis von Salmonellen
WO2008118118A1 (en) * 2007-03-27 2008-10-02 The United States Of America As Represented By The Secretary Of The Army, Walter Reed Army Institute Of Research Artificial invaplex
DE102010018085A1 (de) * 2010-04-23 2011-10-27 Bioserv Analytik Und Medizinprodukte Gmbh Verfahren zur Erkennung einer Salmonelleninfektion
US9492523B2 (en) * 2011-12-09 2016-11-15 The Board Of Regents For Oklahoma State University Broadly protective Shigella vaccine based on type III secretion apparatus proteins

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
FR2567541B1 (fr) * 1984-07-13 1987-02-06 Pasteur Institut Sonde d'adn et procede pour la detection de " shigelles " et des souches entero-invasives de escherichia coli
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5196338A (en) * 1986-12-31 1993-03-23 Praxis Biologics, Inc. Recombinant vectors for Haemophilus influenzae peptides and proteins
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
US5041372A (en) * 1988-11-02 1991-08-20 The United States Of America As Represented By The Department Of Health And Human Services Probe to identify enteroinvasive E. coli and Shigella species
DE3843627A1 (de) * 1988-12-21 1990-07-05 Inst Genbiologische Forschung Kartoffelknollenspezifische transkriptionale regulation
US5594115A (en) * 1990-04-09 1997-01-14 Pharmacia & Upjohn Company Process of purifying recombinant proteins and compounds useful in such process
US5726293A (en) * 1992-10-02 1998-03-10 The General Hospital Corporation Affinity purification methods involving imidazole elution
US5552294A (en) * 1992-10-20 1996-09-03 Children's Medical Center Corporation Rapid detection of virulence-associated factors
US5834247A (en) * 1992-12-09 1998-11-10 New England Biolabs, Inc. Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein
US5747024A (en) * 1993-03-08 1998-05-05 Immunex Corporation Vaccine adjuvant comprising interleukin-15
US5571515A (en) * 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6861247B1 (en) * 1995-11-14 2005-03-01 The General Hospital Corporation Salmonella secreted proteins and uses thereof
US5935824A (en) * 1996-01-31 1999-08-10 Technologene, Inc. Protein expression system
US6303302B1 (en) * 1997-11-19 2001-10-16 The Whitehead Institute For Biomedical Research Regulation of fungal gene expression

Also Published As

Publication number Publication date
DE69923996D1 (de) 2005-04-07
EP1131338B1 (de) 2005-03-02
WO2000023462A1 (en) 2000-04-27
US20070202124A1 (en) 2007-08-30
CA2347937A1 (en) 2000-04-27
AU1227700A (en) 2000-05-08
EP1131338A4 (de) 2002-08-28
EP1131338A1 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
ES2065303T5 (es) Procedimiento de diagnosis y vacuna especifica.
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
FI20115753L (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
FI933328A0 (fi) Antigen producerande protein
NO965621L (no) Nye hIL-4-mutantproteiner som antagonister eller partielle agonister for det humane interleukin 4
DK0764209T3 (da) Albuminekspression i gær
DE59710177D1 (de) Omega-3-fettsäurehaltige zubereitung aus mikroorganismen als prophylaktikum bzw. therapeutikum gegen kokzidiose bei tieren
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
ATE108067T1 (de) Impfstoff und verfahren zur herstellung.
DK0994721T3 (da) Nervevækstfaktor som vaccineadjuvans
ATE184917T1 (de) Rekombinante methode und wirt zur herstellung von xylitol
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
ATE290012T1 (de) Methode für die herstellung von gereinigtem invasinprotein und seine anwendung
EP1168918A4 (de) Impfstoff- und gentherapiezusammensetzungen und verfahren zu ihrer herstellung und verwendung
FI913100A0 (fi) Farmaceutiska preparat.
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
DK0506836T3 (da) BCRF1 proteiner som inhibitorer for interferon-gamma
DE3685917D1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE349531T1 (de) Isolierung und charakterisierung des csa-operons (etec-cs4 pili) und verfahren zu dessen anwendung
BG102707A (bg) Нови триазолопурини, метод за тяхното получаване и тяхното приложение като лекарствени средства

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties